enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Letrozole - Wikipedia

   en.wikipedia.org/wiki/Letrozole

   Letrozole, sold under the brand name Femara among others, is an aromatase inhibitor medication that is used in the treatment of breast cancer for post-menopausal women. [ 1 ] It was patented in 1986 and approved for medical use in 1996. [ 4 ]

3. Aromatase inhibitor - Wikipedia

   en.wikipedia.org/wiki/Aromatase_inhibitor

   Ovarian stimulation with the aromatase inhibitor letrozole has been proposed for ovulation induction in order to treat unexplained female infertility. In a multi-center study funded by the National Institute of Child Health and Development, ovarian stimulation with letrozole resulted in a significantly lower frequency of multiple gestation (i.e., twins or triplets) but also a lower frequency ...

4. Exemestane - Wikipedia

   en.wikipedia.org/wiki/Exemestane

   The most common side effects (more than 10% of patients) are hot flashes and sweating, which are typical of estrogen deficiency as caused by exemestane, and also insomnia, headache, and joint pain. Nausea and fatigue are mainly observed in patients with advanced breast cancer.

5. Regeneron's blood cancer therapy faces setback as FDA ... - AOL

   www.aol.com/news/regenerons-blood-cancer-therapy...

   (Reuters) -Regeneron Pharmaceuticals said on Monday the U.S. FDA has declined approval for its blood cancer therapy for two forms of lymphoma on concerns over the progress of ongoing confirmatory ...

6. Breast cancer management - Wikipedia

   en.wikipedia.org/wiki/Breast_cancer_management

   Breast cancer management takes different approaches depending on physical and biological characteristics of the disease, as well as the age, over-all health and personal preferences of the patient. Treatment types can be classified into local therapy (surgery and radiotherapy) and systemic treatment (chemo-, endocrine, and targeted therapies).

7. US FDA approves Pfizer's blood cancer therapy - AOL

   www.aol.com/news/us-fda-approves-pfizers-blood...

   The FDA approval is based on data from a mid-stage study that showed that 58% of patients treated with Pfizer's therapy had no signs of cancer or had seen a significant decrease in cancer cells in ...

8. Ribociclib - Wikipedia

   en.wikipedia.org/wiki/Ribociclib

   The most common side effects include infections, low levels of white blood cells, headache, cough, nausea (feeling sick), vomiting, diarrhea, constipation, tiredness, hair loss and rash. [ 5 ] Ribociclib was approved for medical use in the United States in March 2017, [ 7 ] [ 8 ] in the European Union in August 2017, [ 5 ] [ 9 ] and in the ...

9. US FDA approves BeiGene's esophageal cancer therapy - AOL

   www.aol.com/news/us-fda-approves-beigenes...

   The therapy, branded as Tevimbra, was approved as a monotherapy for adult patients with unresectable or metastatic esophageal squamous cell carcinoma. The American Cancer Society estimates there ...